X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (164197) 164197
Newspaper Article (20454) 20454
Newsletter (3302) 3302
Magazine Article (2674) 2674
Book Chapter (748) 748
Trade Publication Article (585) 585
Book / eBook (318) 318
Government Document (225) 225
Conference Proceeding (163) 163
Web Resource (112) 112
Dissertation (82) 82
Transcript (43) 43
Book Review (36) 36
Reference (34) 34
Publication (29) 29
Report (11) 11
Journal / eJournal (10) 10
Patent (4) 4
Market Research (2) 2
Paper (2) 2
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (107520) 107520
humans (102128) 102128
life sciences & biomedicine (98511) 98511
female (56510) 56510
male (55503) 55503
animals (53678) 53678
skin (53101) 53101
dermatology (33312) 33312
adult (32904) 32904
middle aged (29564) 29564
skin - drug effects (22793) 22793
mice (21639) 21639
aged (18693) 18693
skin cancer (14734) 14734
research (14658) 14658
care and treatment (14345) 14345
pharmacology & pharmacy (13931) 13931
skin - pathology (13872) 13872
oncology (13336) 13336
skin - metabolism (13243) 13243
skin and connective tissue diseases (13012) 13012
rats (12469) 12469
analysis (12157) 12157
skin diseases (11944) 11944
health aspects (10978) 10978
research article (10672) 10672
treatment outcome (10647) 10647
cancer (10300) 10300
medicine (10116) 10116
melanoma (9993) 9993
adolescent (9985) 9985
immunology (9743) 9743
digestive, oral, and skin physiology (9336) 9336
cell biology (9312) 9312
studies (9143) 9143
time factors (9031) 9031
patients (8934) 8934
surgery (8368) 8368
proteins (8247) 8247
cells, cultured (7927) 7927
inflammation (7584) 7584
medical research (7573) 7573
science & technology - other topics (7542) 7542
skin tests (7506) 7506
risk factors (7355) 7355
skin neoplasms - drug therapy (7328) 7328
dose-response relationship, drug (7276) 7276
biochemistry & molecular biology (7211) 7211
skin neoplasms - pathology (6891) 6891
drug therapy (6746) 6746
clinical trials (6639) 6639
young adult (6530) 6530
multidisciplinary sciences (6500) 6500
child (6483) 6483
gene expression (6382) 6382
administration, cutaneous (6279) 6279
chemistry (6104) 6104
administration, topical (6067) 6067
physical sciences (5971) 5971
cancer therapies (5648) 5648
tumors (5593) 5593
aged, 80 and over (5558) 5558
wound healing (5507) 5507
breast cancer (5421) 5421
apoptosis (5414) 5414
science (5377) 5377
psoriasis (5331) 5331
physiological aspects (5101) 5101
cell line, tumor (5059) 5059
allergy (5036) 5036
skin - blood supply (4973) 4973
medicine, research & experimental (4860) 4860
research & experimental medicine (4846) 4846
skin - cytology (4825) 4825
usage (4740) 4740
medicine & public health (4714) 4714
drugs (4663) 4663
mutation (4646) 4646
metastasis (4629) 4629
integumentary system (4626) 4626
toxicology (4545) 4545
in vitro techniques (4536) 4536
disease models, animal (4508) 4508
biopsy (4351) 4351
dermatitis (4330) 4330
biochemistry (4282) 4282
chemotherapy (4255) 4255
physiology (4221) 4221
cytokines (4218) 4218
diagnosis (4134) 4134
review (4114) 4114
infections (4086) 4086
skin care products (4083) 4083
signal transduction (3990) 3990
rodents (3984) 3984
general & internal medicine (3960) 3960
mice, inbred c57bl (3957) 3957
neurosciences & neurology (3957) 3957
cell line (3906) 3906
fibroblasts - drug effects (3877) 3877
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (101) 101
Online Resources - Online (43) 43
Collection Dvlpm't (Acquisitions) - Vendor file (21) 21
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Gerstein Science - Periodical Stacks (4) 4
St. Michael's Hospital - Stacks (3) 3
Sunnybrook Health Sciences Centre - Holland Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Gerstein Science - Bindery (2) 2
Media Commons - Microtexts (2) 2
Robarts - Stacks (2) 2
Credit Valley Hospital - Reference (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Reference (1) 1
Gerstein Science - Theses (1) 1
Lakeridge Health Sciences - Online (1) 1
Markham Stouffville Hospital - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Online (1) 1
Online Resources - Pharmacy (1) 1
Pharmacy (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
UTL at Downsview - May be requested (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (185123) 185123
German (3066) 3066
Russian (1647) 1647
French (1607) 1607
Japanese (1548) 1548
Chinese (506) 506
Spanish (422) 422
Portuguese (401) 401
Italian (398) 398
Polish (393) 393
Czech (121) 121
Dutch (110) 110
Danish (87) 87
Norwegian (69) 69
Turkish (68) 68
Swedish (62) 62
Hungarian (61) 61
Bulgarian (60) 60
Ukrainian (42) 42
Korean (41) 41
Romanian (34) 34
Croatian (26) 26
Serbian (21) 21
Hebrew (20) 20
Slovak (19) 19
Arabic (16) 16
Finnish (14) 14
Persian (9) 9
Indonesian (3) 3
Icelandic (2) 2
Lithuanian (2) 2
Slovenian (2) 2
Bosnian (1) 1
Catalan (1) 1
Dzongkha (1) 1
Greek (1) 1
Hindi (1) 1
Thai (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International endodontic journal, ISSN 0143-2885, 05/2012, Volume 45, Issue 5, pp. 401 - 412
Seifrtová M, Havelek R, Ćmielová J, Jiroutová A, Soukup T, Brůčková L, Mokrý J, English D, Řezáčová M. The response of human ectomesenchymal dental pulp stem... 
apoptosis | Mitogen‐activated protein kinases | human dermal fibroblasts | cisplatin | dental pulp stem cells | p53 | Human dermal fibroblasts | Dental pulp stem cells | Cisplatin | Apoptosis | Mitogen-activated protein kinases | P53 | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Mutagens - toxicity | Phosphorylation | Skin - cytology | Cyclin-Dependent Kinase Inhibitor p21 - drug effects | Ectoderm - drug effects | Extracellular Signal-Regulated MAP Kinases - drug effects | Apoptosis - drug effects | Humans | Caspase 9 - drug effects | Caspase 8 - drug effects | Cisplatin - toxicity | Caspase 3 - drug effects | Cell Culture Techniques | JNK Mitogen-Activated Protein Kinases - drug effects | Cell Survival - drug effects | Mesenchymal Stromal Cells - drug effects | Caspase 7 - drug effects | Cytostatic Agents - toxicity | Dental Pulp - cytology | Dental Pulp - drug effects | Enzyme Activation - drug effects | Tumor Suppressor Protein p53 - drug effects | Ectoderm - cytology | p38 Mitogen-Activated Protein Kinases - drug effects | MAP Kinase Signaling System - drug effects | Serine - drug effects | Fibroblasts - drug effects | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Cell Cycle - drug effects | Skin - drug effects | Proteins | Antimitotic agents | Analysis | Stem cells | Universities and colleges | Antineoplastic agents | Tumor proteins | Protein kinases | Phosphotransferases
Journal Article
Cutaneous and ocular toxicology, ISSN 1556-9527, 2005
Journal
Cancer treatment reviews, ISSN 0305-7372, 2016, Volume 44, pp. 51 - 60
Highlights • Role of immune checkpoint inhibition in the management of key malignancies. • Description of rates of immune-related adverse events and timing of... 
Hematology, Oncology and Palliative Medicine | Pembrolizumab | Immune-related adverse events | Renal cancer | Ipilimumab | Nivolumab | Lung cancer | Melanoma | Immune-checkpoint inhibitors | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Adrenal Cortex Hormones - therapeutic use | Diarrhea - chemically induced | Infliximab - therapeutic use | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Colitis - chemically induced | Antilymphocyte Serum - therapeutic use | Colitis - drug therapy | Carcinoma, Renal Cell - drug therapy | Chemical and Drug Induced Liver Injury - etiology | Pituitary Diseases - chemically induced | Pituitary Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Neoplasms - drug therapy | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Melanoma - drug therapy | Chemical and Drug Induced Liver Injury - drug therapy | Diarrhea - drug therapy | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Thyroiditis - drug therapy | Thyroiditis - chemically induced | Index Medicus
Journal Article
Oncogene, ISSN 1476-5594, 2003, Volume 22, Issue 20, pp. 3138 - 3151
.... A large set of genetic, functional and biochemical studies suggest that melanoma cells become 'bullet proof' against a variety of chemotherapeutic drugs by exploiting their intrinsic resistance... 
Drug resistance | Cancer therapy | Chemotherapeutic targets | Apoptosis | Skin cancer | Biochemistry & Molecular Biology | Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Caspase 9 | Skin Neoplasms - drug therapy | Apoptosis - drug effects | Microtubule-Associated Proteins - metabolism | Humans | NF-kappa B - metabolism | Microtubule-Associated Proteins - drug effects | Proto-Oncogene Proteins c-bcl-2 - metabolism | Caspases - metabolism | PTEN Phosphohydrolase | Melanocytes - drug effects | Neoplasm Proteins | Caspases - drug effects | Antineoplastic Agents - pharmacology | Cell Survival - physiology | Skin Neoplasms - pathology | Apoptotic Protease-Activating Factor 1 | Cell Survival - drug effects | Tumor Suppressor Proteins - metabolism | Inhibitor of Apoptosis Proteins | Signal Transduction | Mitochondria - metabolism | Melanoma - pathology | Mitochondria - drug effects | Disease Progression | Animals | Proteins - metabolism | Melanoma - drug therapy | Proto-Oncogene Proteins c-bcl-2 - drug effects | Proteins - drug effects | Apoptosis - physiology | Phosphoric Monoester Hydrolases - metabolism | Tumor Suppressor Protein p14ARF - metabolism | Drug Resistance, Neoplasm - physiology | NF-kappa B - drug effects | Tumor Suppressor Protein p14ARF - drug effects
Journal Article
Skin pharmacology and physiology, ISSN 1660-5535, 2004
Journal
Journal of clinical oncology, ISSN 1527-7755, 2012, Volume 30, Issue 21, pp. 2691 - 2697
.... Recently, ipilimumab was approved by the US Food and Drug Administration for the treatment of metastatic melanoma... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Stevens-Johnson Syndrome - immunology | Peripheral Nervous System Diseases - chemically induced | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Scleritis - chemically induced | Antineoplastic Agents - administration & dosage | Liver - immunology | Liver - drug effects | Antineoplastic Agents - adverse effects | Diarrhea - immunology | Pancreatitis - immunology | Scleritis - immunology | Mucous Membrane - drug effects | Colitis - immunology | Peripheral Nervous System Diseases - immunology | Antibodies, Monoclonal - immunology | Drug Eruptions - immunology | Skin - immunology | Melanoma - metabolism | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Antineoplastic Agents - immunology | CTLA-4 Antigen - drug effects | Lymphatic Diseases - immunology | Antibodies, Monoclonal - pharmacokinetics | CTLA-4 Antigen - immunology | Pancreatitis - chemically induced | Melanoma - secondary | Chemical and Drug Induced Liver Injury - immunology | Pituitary Gland - immunology | Skin Neoplasms - metabolism | Lymphatic Diseases - chemically induced | Mucous Membrane - immunology | Antibodies, Monoclonal - administration & dosage | Melanoma - immunology | Uveitis - immunology | Melanoma - drug therapy | Uveitis - chemically induced | Pituitary Gland - drug effects | Skin - drug effects | Index Medicus
Journal Article
Neuropsychopharmacology (New York, N.Y.), ISSN 1740-634X, 07/2014, Volume 40, Issue 2, pp. 327 - 337
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2014, Volume 135, Issue 6, pp. 1625 - 1635.e5
Background Remodeling of quiescent vessels with increases in permeability, vasodilatation, and edema are hallmarks of inflammatory disorders. Factors involved... 
Allergy and Immunology | Peroxisome proliferator-activated receptor β/δ | smooth muscle cells | endothelium | anaphylaxis | vascular permeability | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Edema - genetics | Myocytes, Smooth Muscle - pathology | Capillary Permeability - drug effects | Capillary Permeability - immunology | Hypothermia - immunology | Intercellular Junctions - immunology | Hypothermia - pathology | Proto-Oncogene Proteins c-akt - genetics | Thrombin - pharmacology | Intercellular Junctions - pathology | Anaphylaxis - immunology | PPAR delta - immunology | Female | Mitogen-Activated Protein Kinases - immunology | Myocytes, Smooth Muscle - drug effects | Vascular Endothelial Growth Factor A - pharmacology | PPAR delta - genetics | Skin - pathology | Skin - immunology | PPAR delta - deficiency | Edema - immunology | Histamine - pharmacology | Signal Transduction | Anaphylaxis - pathology | Gene Expression Regulation | Mice, Transgenic | PPAR-beta - immunology | PPAR-beta - genetics | PPAR-beta - deficiency | Anaphylaxis - genetics | Endothelial Cells - immunology | Skin - blood supply | Animals | Proto-Oncogene Proteins c-akt - immunology | Intercellular Junctions - drug effects | Myocytes, Smooth Muscle - immunology | Mitogen-Activated Protein Kinases - genetics | Mice | Endothelial Cells - pathology | Edema - pathology | Hypothermia - genetics | Skin - drug effects | Endothelial Cells - drug effects | Mitogen-Activated Protein Kinases/genetics | Skin/blood supply | Endothelial Cells/drug effects | Endothelial Cells/immunology | Intercellular Junctions/immunology | PPAR delta/immunology | Skin/pathology | Intercellular Junctions/drug effects | Hypothermia/genetics | Capillary Permeability/drug effects | Life Sciences | PPAR delta/genetics | PPAR delta/deficiency | Hypothermia/immunology | Anaphylaxis/genetics | Histamine/pharmacology | PPAR-beta/immunology | Myocytes, Smooth Muscle/pathology | Anaphylaxis/pathology | Myocytes, Smooth Muscle/immunology | Endothelial Cells/pathology | Hypothermia/pathology | Vascular Endothelial Growth Factor A/pharmacology | Mitogen-Activated Protein Kinases/immunology | Myocytes, Smooth Muscle/drug effects | Edema/immunology | Proto-Oncogene Proteins c-akt/genetics | Edema/pathology | Skin/immunology | Intercellular Junctions/pathology | Proto-Oncogene Proteins c-akt/immunology | Edema/genetics | PPAR-beta/genetics | Skin/drug effects | PPAR-beta/deficiency | Thrombin/pharmacology
Journal Article